1. News
  2. Blog
  3. Vanderbilt-GSK DPAc Request for Proposals

Vanderbilt-GSK DPAc Request for Proposals

04/20/2017

GlaxoSmithKline (GSK) is hoping to fund collaboration with Vanderbilt inventors for drug discovery. They are looking for protein targets to collaborate with their small molecule collection.

Selected small molecule projects will receive $150K of joint Vanderbilt-GSK funding for assay development and/or translational research around the protein target.

Key selection criteria–

1.A new drug target with an understanding of the pharmacology (e.g. antagonist, agonist) within a disease relevant pathway.
2.A coherent therapeutic hypothesis based on sound understanding of the pathological mechanism in any disease area.

Selected small molecule projects will receive–

1.$150K of joint Vanderbilt-GSK research funding for assay development and/or translational research around the target in your lab.
2.GSK to provide a high throughput screen and/or encoded library screen of your selected target with you contributing to the hit triaging and confirmation process.
3.GSK may provide up to 3 chemical structures of selected tools to Investigators to help further their research and potentially lead to high-impact publications.
4.Promising results may lead to a collaboration between the Investigator and the DPAc team to create a novel medicine.
 

Who you are –A Vanderbilt principal investigator with the unique know-how and key expertise that is essential for a successful drug discovery collaboration. 

The DPAc collaborative model –The Discovery Partnerships with Academia (DPAc) model (http://www.dpac.gsk.com/) was established to bring together the insight and creativity of the academic world with the drug discovery expertise of GlaxoSmithKline.  We are a dedicated team of experienced drug discovery scientists – internal champions for your project and a gateway to the global resources of GSK.  Our goal is to establish truly integrated partnerships that can translate innovative research into medicines that benefit patients.

The deadline for submissions is June 30, 2017.

 

 

Apply Here